Innate Pharma SA
Mathilde Meurillon has extensive experience in communication and investor relations, currently serving as Directrice associée at Innate Pharma since November 2015, where responsibilities include corporate and internal communication management. Prior positions at Innate Pharma included Senior Communication Manager and Financial Communication Manager. Mathilde has also worked at Tenergie and Synergie Solaire, focusing on marketing tools and external communication. Earlier experience includes roles at HAVAS 360, Orange, Tape à l'oeil, Crédit Mutuel Nord Europe, and Auchan, encompassing project management, event organization, and internal communications. Mathilde holds multiple degrees, including a Master's in Corporate Communication and Change Management from IAE Aix en Provence and a Master's in Management from SKEMA Business School.
Previous companies
This person is not in any teams
This person is not in any offices
Innate Pharma SA
2 followers
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.